Technology News and Research

RSS

Scientists create fungi with additional foreign genes to produce chemicals for drugs

Usually, mould fungi are nothing to cheer about - but now they can be used as "chemical factories". Scientists at the Vienna University of Technology have succeeded in introducing bacterial genes into the fungus Trichoderma, so that the fungus can now produce important chemicals for the pharmaceutical industry. The raw material used by the fungus is abundant - it is chitin, which makes up the shells of crustaceans.

14 Feb 2012

Tips to reduce car accident risk among teens

Teenage drivers are four times more likely than an adult driver to get into a car accident according to the Centers for Disease Control. The elevated risk comes in wake of a young driver's inexperience coupled with the natural tendency to want to test or break the rules. As a car accident lawyer in San Diego, there are many cases that come across my desk involving young, inexperienced drivers.

14 Feb 2012

Ensysce announces latest data on delivery platform for therapeutic siRNA

Ensysce Biosciences Inc. announced today the publication of their latest data on their delivery platform for short interfering RNA (siRNA) for therapeutic purposes in the journal Materials.

14 Feb 2012

Merck Serono, Mendor sign blood glucose meter distribution agreement

Mendor, the Finnish diabetes technology company, continues its rapid growth and is excited to announce yet another international partnership - now opening the United Kingdom for its innovative products. Mendor has just signed a distribution agreement with a leading pharmaceutical company in the Diabetes field Merck Serono, covering the United Kingdom diabetes market.

14 Feb 2012

Knee replacements double in 10 years, study says

More than 4 million Americans over 50 have artificial knees, according to a new study. ... "These data are sobering because we didn't know what an army of people we've created over the last decade," said study author Elena Losina, co-director of the Orthopedics and Arthritis Center for Outcomes Research at Harvard's Brigham and Women's Hospital. ... Artificial knees also wear out after a period of time, so as the operations are increasingly done on younger Americans, many will live long enough to almost certainly need a second or even third knee replacement.

14 Feb 2012

Microsoft, GE announce several developments for planned joint venture

General Electric Co. (GE), through its healthcare IT business, and Microsoft Corp. today announced several developments for their planned 50-50 joint venture, including the intention to demonstrate future product capabilities at HIMSS12, the year's largest healthcare IT trade show, later this month.

14 Feb 2012

UT Southwestern installs new system to deliver precise radiation therapy

UT Southwestern Medical Center has installed a new system to deliver extremely precise and individualized radiation treatment, assuring that cancer patients in the region have access to the latest advances in radiation oncology.

14 Feb 2012

Insight into factors that affect Medicare decisions on CMS's coverage of medical technology

A new study by researchers at Tufts Medical Center provides unique insight into factors that affect Medicare decisions on whether to pay for medical technologies.

14 Feb 2012

Air pollution may accelerate cognitive decline in older women

A large, prospective study led by a researcher at Rush University Medical Center indicates that chronic exposure to particulate air pollution may accelerate cognitive decline in older adults.

14 Feb 2012

New software key for personalized cancer medicine

High-throughput DNA sequencing technologies are leading to a revolution in how clinicians diagnose and treat cancer. The molecular profiles of individual tumors are beginning to be used in the design of chemotherapeutic programs optimized for the treatment of individual patients.

14 Feb 2012

Pacific Biosciences releases major upgrade to PacBio RS system

Pacific Biosciences of California, Inc., provider of Single Molecule Real Time sequencing products, today announced it has released a major upgrade to its PacBio RS system, referred to as "C2", including new chemistry, enhanced SMRT Cells and upgraded software, which together provide customers with significant performance increases for DNA sequencing.

13 Feb 2012

Third patient dosed in Phase 1/2 SMD trial using RPE cells derived from hESCs

Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, announced today the dosing of third patient in its Phase 1/2 trial for Stargardt's macular dystrophy (SMD) using retinal pigment epithelial (RPE) cells derived from human embryonic stem cells (hESCs).

13 Feb 2012

InComm announces acquisition of Medagate

InComm, a leading prepaid product and transaction services company, announced today that it has acquired Medagate Corporation, the company that powers OTCNetwork, the only national closed loop over-the-counter (OTC) healthcare benefits payments platform.

13 Feb 2012

Forbes examines how mobile phones are improving access to care in developing world

Mobile phones are improving access to health care in the developing world, according to the series "The Future of mHealth" by Mobiledia, a Forbes contributor.

13 Feb 2012

Bode announces acquisition of Chromosomal Laboratories

Bode Technology, a leading provider of forensic DNA services, announced today the acquisition of Chromosomal Laboratories, Inc., a leading provider of DNA testing for immigration and private paternity.

13 Feb 2012

DARPA awards fourth milestone payment of $3.56M to Medicago

Medicago USA Inc., a wholly owned subsidiary of Medicago Inc., a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has received the fourth milestone payment of US$3.56 million from the Defense Advanced Research Projects Agency.

13 Feb 2012

Most pharmas concerned over ability to meet EMA EVMPD deadline

Polling conducted by Virtify, Inc. revealed that most pharmaceutical companies are concerned about their ability to comply with the requirement to submit additional pharmacovigilance data to the EMA EudraVigilance Medicinal Product Dictionary (EVMPD) in advance of the July 2, 2012 deadline.

13 Feb 2012